Experiences with the use of oxaliplatin in esophageal carcinoma

Author： Albertsson Maria   Kadar Lianna   Bergenfeldt Magnus  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.1, 2006-02, pp. : 103-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Esophageal tuberculosis misdiagnosed as esophageal carcinoma

By Hu Min  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 3, 2008-03 ,pp. : 140-141

Springer Publishing Company

Access to resources Recommend Favorite

Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells

By Du Hailei   Yang Weiping   Chen Lin   Shi Mingming   Seewoo Varun   Wang Jiayu   Lin Andy   Liu Zhuoran   Qiu Weihua  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 143-150

Spandidos Publications

Access to resources Recommend Favorite

Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 196-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preoperative treatment of locally advanced esophageal carcinoma (Review)

By                        

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1745-1753

Spandidos Publications

Access to resources Recommend Favorite

Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma

By Rahadiani Nur  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1311-1323

Springer Publishing Company

Access to resources Recommend Favorite